New research being presented at this year’s European Congress on Obesity (ECO) in Venice, Italy (12-15 May), identifies the optimum body weight range for adults with type 2 diabetes to minimize their risk of dying from any cardiovascular disease, including heart failure, heart disease, stroke, and chronic kidney disease.
Lonza’s modest forecast for cell and gene therapies points to uncertainty about sector’s future
As Lonza unveiled its four-year financial predictions on Tuesday, observers were left unsure about the CDMO’s cell and gene therapy (CGT) forecast. Nonetheless, they were
October 20, 2023